Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 6
2005 3
2006 4
2007 10
2008 9
2009 7
2010 10
2011 13
2012 17
2013 24
2014 30
2015 37
2016 24
2017 26
2018 32
2019 28
2020 42
2021 44
2022 51
2023 58
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Results by year

Filters applied: . Clear all
Page 1
Nutrition and Cardiovascular Diseases.
Fukumoto Y. Fukumoto Y. Nutrients. 2021 Dec 27;14(1):94. doi: 10.3390/nu14010094. Nutrients. 2021. PMID: 35010969 Free PMC article.
Sarcopenia as a comorbidity of cardiovascular disease.
Sasaki KI, Fukumoto Y. Sasaki KI, et al. Among authors: fukumoto y. J Cardiol. 2022 May;79(5):596-604. doi: 10.1016/j.jjcc.2021.10.013. Epub 2021 Dec 11. J Cardiol. 2022. PMID: 34906433 Free article. Review.
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
Kanaoka K, Onoue K, Terasaki S, Nakano T, Nakai M, Sumita Y, Hatakeyama K, Terasaki F, Kawakami R, Iwanaga Y, Miyamoto Y, Saito Y; Japanese Registry of Fulminant Myocarditis Investigators. Kanaoka K, et al. Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27. Circulation. 2022. PMID: 36164974
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
Taguchi I, Iimuro S, Iwata H, Takashima H, Abe M, Amiya E, Ogawa T, Ozaki Y, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Fukumoto Y, Hokimoto S, Miyauchi K, Yamazaki T, Ito H, Otsuji Y, Kimura K, Takahashi J, Hirayama A, Yokoi H, Kitagawa K, Urabe T, Okada Y, Terayama Y, Toyoda K, Nagao T, Matsumoto M, Ohashi Y, Kaneko T, Fujita R, Ohtsu H, Ogawa H, Daida H, Shimokawa H, Saito Y, Kimura T, Inoue T, Matsuzaki M, Nagai R. Taguchi I, et al. Among authors: fukumoto y. Circulation. 2018 May 8;137(19):1997-2009. doi: 10.1161/CIRCULATIONAHA.117.032615. Circulation. 2018. PMID: 29735587 Free PMC article. Clinical Trial.
History of cardiovascular epidemiology in Japan.
Adachi H, Fukumoto Y. Adachi H, et al. Among authors: fukumoto y. J Cardiol. 2023 Feb;81(2):196-201. doi: 10.1016/j.jjcc.2022.07.021. Epub 2022 Aug 26. J Cardiol. 2023. PMID: 36038487 Free article. Review.
Author's reply.
Sasaki KI, Fukumoto Y, Kakuma T. Sasaki KI, et al. Among authors: fukumoto y. J Cardiol. 2020 Dec;76(6):636-637. doi: 10.1016/j.jjcc.2020.06.012. Epub 2020 Aug 13. J Cardiol. 2020. PMID: 32800411 Free article. No abstract available.
Rho-kinase inhibitors.
Fukumoto Y, Shimokawa H. Fukumoto Y, et al. Handb Exp Pharmacol. 2013;218:351-63. doi: 10.1007/978-3-642-38664-0_14. Handb Exp Pharmacol. 2013. PMID: 24092347 Review.
410 results